Bosnalijek's product portfolio encompasses 176 drugs based on 90 different generic names, for peroral, parenteral and topical use with an effect on digestive system and metabolism, cardiovascular system, systemic infections, skin, skeletomuscular, nervous and respiratory system, as well as systemic hormone drugs with the exception of sex hormones.

The result of the development of our own technology are 142 products or 80% of total portfolio out of which 35 products are from the 1991portfolio, while all the remaining products are all new products.

Bosnalijek is permanently oriented toward its clients whose needs we carefully monitor and analyze with special care. The result is a wide range of drugs adapted to the users' needs. The drugs are manufactured in the form of ampoules, tablets, film-coated tablets, capsules, balms, gels, emulsions, suspensions and syrups.

The permanent foundation of our manufacturing & sales range are prescription drugs from all pharmacotherapeutic groups the most important of which are cardiovascular drugs. They are followed by the drugs with an effect on digestive tract, metabolism and nervous system and the drugs for the treatment of systemic infections.

Bosnalijek's leading brand from the group of cardiovascular drugs is Lopril, as much on the market of Bosnia and Herzegovina, as on export markets. It is intended for treatment of high blood pressure, as well as for prevention and treatment of chronic heart failure and renal complication in diabetes.

By following world self-healing trends, Bosnalijek continues to invest in the development of products from its over-the counter (OTC) range. These products are intended for prevention and attenuation of certain symptoms and minor health problems such as pain, raised body temperature, digestive, cardiovascular, rheumatic, psychic and climacteric disorders when there is a need for certain vitamins and minerals, as well as for improvement of general condition and strengthening of organism immunity.

All of Bosnalijek's manufacturing is performed in three manufacturing facilities: facility for the manufacturing of solid oral forms of the drugs, facility for the manufacturing of sterile drugs in ampoules and facility for the manufacturing of unsterile semi-solid and liquid forms of the drugs. The facilities are modern and designed in accordance with international standards, which ensures Bosnalijek its reputation of a manufacturer of the drugs with highest quality standards.

Bosnalijek successfully cooperates with worldly renowned pharmaceutical companies such as Lek Sandoz, Hoffman La Roche and Eli Lilly.